Accessibility StatementSkip Navigation STAMFORD, Conn., Sept. 25, 2025 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA /OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the third quarter ended September 30, 2025 after market close on November 5, 2025. Management will host a conference call and audio webcast that afternoon at 5:00 p.m. ET consisting of prepared remarks ...

Industry Overview - The U.S. cannabis industry is experiencing significant growth, with legal sales surpassing $33 billion in 2024 and projected revenues of $50 billion by 2030 [1][3] - Expansion into new adult-use markets and growth in medical programs are creating new opportunities [1][3] - Federal rescheduling and potential banking reforms are increasing optimism in the sector [1][2] Key Companies - Trulieve Cannabis Corp. operates 231 retail dispensaries and has a strong presence in Florida, with a cultivation and processing footprint of over four million square feet [4][7] - Curaleaf Holdings, Inc. operates in 19 states with 154 retail dispensaries and has recently consolidated its international business, enhancing its global position [8][10] - Green Thumb Industries, Inc. operates over 101 retail locations and 20 manufacturing facilities, focusing on both adult-use and medical markets [12][14] Financial Performance - Trulieve reported $302 million in revenue for Q2 2025, with a gross margin of 61% and adjusted EBITDA of $111 million [7][15] - Curaleaf's Q2 2025 net revenue was $314.5 million, an 8% decline from the previous year, with a gross margin of 49% [10][11] - Green Thumb Industries reported Q2 2025 revenue of $293.3 million, a 4.7% increase year-over-year, with a gross margin of 49.9% [14][15] Market Positioning - Trulieve is recognized for its retail penetration and product distribution, supported by a large loyalty program with over 725,000 members [4][7] - Curaleaf's extensive retail and wholesale network positions it well for continued expansion, despite recent revenue challenges [8][11] - Green Thumb's strategy combines brand development with an expanding retail footprint, contributing to steady sales growth [12][14] Investment Considerations - The cannabis sector remains volatile, necessitating careful technical analysis and disciplined risk management for traders [1][2] - Companies with strong fundamentals and expanding footprints are likely to benefit from ongoing industry developments [2][15] - Investors are advised to monitor technical setups while applying risk management strategies to navigate the market effectively [16]

Financial Performance - Kingstone's core direct written premium grew by 17% compared to Q2 2024[6] - Net investment income increased by 30% compared to Q2 2024, with an average portfolio yield of 393%[6] - The company's combined ratio improved to 715% in Q2 2025, compared to 782% in Q2 2024[70] - Adjusted EBITDA increased by 884% to $14783 thousand in Q2 2025, compared to $7845 thousand in Q2 2024[70] - Net income rose by 1492% to $11252 thousand in Q2 2025, compared to $4515 thousand in Q2 2024[70] Strategic Initiatives - Kingstone's "Select" product has a ~31% lower frequency than the "Legacy" product, indicating improved risk selection[18] - Select policies represent 48% of policies in force as of June 30, 2025[18] - The company achieved a NY growth of +31% in FY2024[49] - Kingstone estimates approximately $12 million in premiums from the AmGuard renewal rights transaction, beginning September 1, 2025[47] Future Outlook - Kingstone anticipates net premiums earned of ~$187 million for fiscal year 2025[51] - The company aims to reach ~$500 million in direct premiums written by 2029[57]